In a tense congressional hearing that erupted into confrontation, Robert F. Kennedy Jr., as Health and Human Services Secretary, clashed with Representative Suzan DelBene over Medicare reforms that are delaying critical care for patients. DelBene accused the administration of betraying promises not to cut Medicare, spotlighting the WISEr model’s use of AI to deny treatments, leaving people like a Washington state senior in agony for weeks.
The exchange began with DelBene pressing Kennedy on a recent CMS policy overhaul, where private companies now wield AI to scrutinize Medicare claims. She referenced Kennedy’s own words from a June 2025 press release, decrying the pitting of patients against massive corporations, only for his agency to implement a system doing exactly that. “Americans shouldn’t have to negotiate with their insurer,“ Kennedy had said, yet the WISEr model is now forcing exactly that scenario.
One harrowing case dominated the discussion: Joanne, a senior from Washington with a herniated disc causing excruciating sciatic pain. Her doctor prescribed a simple injection that would alleviate her suffering, but under the new rules, it’s been stalled for over six weeks. DelBene described Joanne’s ordeal—relying on crutches, worsening arthritis, and multiple falls—including one just days ago that left her more vulnerable.
Kennedy attempted to defend the policy, arguing it targets waste in Medicare, pointing to a staggering $23 billion spent on skin substitutes alone due to lax oversight. “There’s tremendous waste,“ he insisted, noting that prior authorization rates in private insurance hover at 30%, compared to just 5% in traditional Medicare before this change. But DelBene fired back, labeling the WISEr model as outright harmful.
The confrontation intensified when DelBene directly challenged Kennedy: “Do you think Joanne’s treatment, which would allow her to walk with less pain, is wasteful?“ Kennedy’s response—“Do you want me to actually answer that question?“—drew sharp criticism, underscoring what critics see as evasion. He admitted the outcome for patients like Joanne was “terrible“ and unintended, but insisted the broader goal was to curb fraud.
DelBene didn’t let up, linking the policy to President Trump’s repeated campaign vows not to “lay a finger on Medicare.“ She accused Kennedy of approving a model that directly contradicts those promises, with real people suffering in states like Washington. Stories poured in: patients denied care, conditions deteriorating, and costs ballooning as delays lead to more expensive interventions down the line.
The hearing revealed a pattern of administrative indifference. DelBene noted she sent a detailed letter to CMS last August outlining her concerns about WISEr, yet received no response until this very session. Kennedy apologized for the delay, citing an “unprecedented number of communications from Congress,“ and pledged to address it publicly. But for DelBene, it was too little, too late.
This clash isn’t isolated; it’s symptomatic of a larger crisis in healthcare access. Across six states, including Washington, the WISEr model’s rollout has sparked outrage, with advocates warning of a slippery slope toward privatization of Medicare. Patients are 𝒄𝒂𝓊𝓰𝒉𝓉 in the crossfire, their health held hostage by algorithms designed for cost savings over human needs.
Kennedy tried to pivot, emphasizing potential long-term benefits, like reducing the $23 billion in questionable expenditures. Yet, his explanations fell flat against the human toll. DelBene’s pointed query—“You are hurting patients for no reason“—echoed the frustration of constituents who feel abandoned by their government.
As the hearing wrapped, DelBene submitted for the record a dossier of similar stories, underscoring the widespread impact. This isn’t just policy debate; it’s a matter of life-altering consequences for everyday Americans. The administration now faces mounting pressure to rethink WISEr before more lives are disrupted.
Experts are weighing in, with healthcare analysts decrying the model’s reliance on AI without sufficient safeguards. One prominent physician group called it a “dangerous experiment“ that prioritizes corporate profits over patient welfare. The fallout could reshape Medicare’s future, potentially eroding public trust in federal health programs.
In Washington state alone, reports of denied claims have surged, straining local healthcare systems. Hospitals are reporting longer wait times and increased emergency visits as patients seek alternatives to denied treatments. This hearing might be the catalyst for reform, forcing a reckoning on promises made versus actions taken.
Kennedy’s role in this 𝒹𝓇𝒶𝓂𝒶 adds a layer of irony. Once a vocal critic of big government and corporate influence, his defense of WISEr paints a picture of policy compromises that alienate his base. DelBene’s relentless questioning 𝓮𝔁𝓹𝓸𝓼𝓮𝓭 vulnerabilities in the administration’s narrative, turning a routine oversight session into a national headline.
The urgency is palpable: with Medicare serving millions, any delay in care can mean irreversible harm. As this story unfolds, lawmakers are demanding immediate answers and potential rollbacks. The American public deserves better than bureaucratic red 𝓉𝒶𝓅𝑒 that endangers lives.
This breaking development highlights the need for transparency and accountability in healthcare policy. As investigations continue, the fate of programs like WISEr hangs in the balance, with patients’ stories at the forefront of the fight. The coming days will reveal whether words from the campaign trail hold any weight in the halls of power.